Expression of β-tubulin III and Survivin in Advance Stage Breast Cancer Correlates with Chemotheraputic Effects of Docetaxel |
Yuan, Shao-Fei
(Cancer Center, the Third Affiliated Hospital, Wenzhou Medical College)
Zhu, Lin-Jia (Cancer Center, the Third Affiliated Hospital, Wenzhou Medical College) Zheng, Wei-E (Cancer Center, the Third Affiliated Hospital, Wenzhou Medical College) Chen, Hua (Cancer Center, the Third Affiliated Hospital, Wenzhou Medical College) Wu, Li-Li (Cancer Center, the Third Affiliated Hospital, Wenzhou Medical College) Zhang, Wu (Cancer Center, the Third Affiliated Hospital, Wenzhou Medical College) Sun, Hong-Yu (Cancer Center, the Third Affiliated Hospital, Wenzhou Medical College) Chen, Wen-Jun (Cancer Center, the Third Affiliated Hospital, Wenzhou Medical College) |
1 | Altieri DC (2003). Validating survivin as a cancer therapeutic target. Nat Rev Cancer, 3, 462. |
2 | Banerjee A (2002). Increased levels of tyrosinated alpha-beta (III)-and beta(IV)-tubulin isotypes in paclitaxel-resistant MCF-7 breast cancer cells. Biochem Biophys Res Commun, 293, 598-601. DOI |
3 | Biganzoli L, Minisini A, Aapro M, et a1 (2004). Chemotherapy for metastatic breast cancer. Curr Opin Obstet Gynecol, 16, 37-41. DOI |
4 | Campone M, Blasinska-Morawiec M, Tekiela A, et a1 (2009). Phase II study of vinorelbine (altemating intravenous and oral)in combination with docetaxel as first-line chemotherapy in metastatic breast cancer. Cancer Chemother Pharmacol, 63, 937-43. DOI |
5 | Grisko T,Williams A, Turkson J, et al (2006). Persistent activation of state signaling induces survivin gene expression and confers resistance to apoptosis in human breast cancer cells. Clin Cancer Res, 12, 11-9. DOI |
6 | Jones SE, Erban J, Ovemoyer B, et a1(2005). Randomized phaseⅢ study of docetaxel compared with paclitaxel in metastatic breast cancer. Clin Oncol, 23, 5542-51. DOI |
7 | Kappler M, Rot S, Taubert H, et al (2007). The effects of knockdown of wild-type survivin, survivin-2B or survivindelta3 on the radiosensitization in a soft tissue sarcoma cells in vitro under different oxygen conditions. Cancer Gene Ther, 14, 994-1001. DOI |
8 | Khan MA, Carducci MA, Partin AW (2003). The evolving role of docetaxel in the management of androgen independment prostate cancer. J Urol, 170, 1709- 16. DOI |
9 | Ranganathan S, Benetatos CA, Colarusso PJ, et al (2008). Altered-tubulin isotype expression in paclitaxel resistant human prostate carcinoma cells. Br J Cancer, 77, 562-6. DOI |
10 | Wang W Ouyang X, Zhang X (2006). Therapeutic effects of survivin and bcl-2 gene combined with antisense oligodeoxynucleotide on human breast cancer transplanted subcutaneously in nude mice. Chinese J Clin Pharmacol Therapeutics, 11, 1164-7. |